Hatipoglu 2010.

Methods	Randomized
Participants	Adults (no age mentioned) Hospitalized CAP, moderately‐severe
Interventions	Atypical: ceftriaxone + clarithromycin Non‐atypical: ceftriaxone
Outcomes	Success rate Incremental cost‐effectiveness analysis
Notes	Data extracted from abstract, no correspondence
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Not described
Allocation concealment (selection bias)	Unclear risk	Not described
Incomplete outcome data (attrition bias) Mortality	Unclear risk	Not described
Incomplete outcome data (attrition bias) Failure	Low risk	All patients evaluated
Selective reporting (reporting bias)	Unclear risk	Not described
Other bias	Unclear risk	Not enough data
Blinding of participants and personnel (performance bias) All outcomes	Unclear risk	Not enough data
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Not enough data